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Abstract
Background: Eating disorders during pregnancy can affect fetal growth and the child’s early development,
but the underlying mechanisms have not been elucidated. The aim of the present study was to investigate
serum biomarkers of nutrition and stress in pregnant women with previous eating disorders compared to
controls and in relation to head circumference and early neurocognitive development of the offspring.
Methods: In a longitudinal cohort study, pregnant nulliparous non-smoking women with a history of anorexia
nervosa (n = 20), bulimia nervosa (n = 17) and controls (n = 59) were followed during pregnancy and their
children’s growth and neurocognitive development were followed up to five years of age. We investigated
maternal serum biomarkers of nutrition and stress (ferritin, cortisol, thyroid-stimulating hormone, free thyroxine, insulin,
insulin-like growth factor I (IGF-I) and IGF binding protein 1) in blood samples collected during early pregnancy and
compared between groups (ANOVA, LSD post-hoc test). The results were related to previous data on head
circumference at birth and neurocognitive development at five years of age of the offspring (Spearman rank
correlation or Pearson correlation test).
Results: Serum levels of ferritin in the women with previous anorexia nervosa, but not in those with a
history of bulimia nervosa, were significantly lower than in the controls (p < 0.01), and correlated strongly
to impaired memory function in their children (rs = −0.70, p < 0.001). Maternal serum levels of free thyroxine were
similar between groups but correlated positively to reduced head circumference at birth of the children in
the bulimia nervosa group (r = 0.48, p < 0.05), and with the same tendency in the anorexia nervosa group
(r = 0.42, p = 0.07), but not in the controls (r = 0.006). There were no significant differences in cortisol or the
other biomarkers between groups.
Conclusions: Low maternal serum ferritin in women with previous anorexia nervosa may be of importance
for impaired memory capacity in the offspring at five years of age. Our results also indicate that thyroxin
levels in pregnant women with previous eating disorders are positively associated with fetal head growth.
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Background
Eating disorders (ED) during pregnancy may negatively
affect intrauterine growth of the offspring. Previous
studies have shown that particularly anorexia nervosa
(AN) is associated with higher rates of prematurity,
small for gestational age (SGA) and lower birthweight
[1–4]. Furthermore, in a longitudinal cohort study we
previously reported reduced head circumference in
infants of mothers with a history of AN or bulimia
nervosa (BN) [1]. The reduced head circumference at
birth was related to delayed neurocognitive develop-
ment, particularly expressive language skills, at five years
of age in the group of children of mothers with a
history of ED [5]. We hypothesized that impaired
nutrition and/or maternal stress during pregnancy
may be the underlying mechanisms.
A number of maternal serum biomarkers have been
associated with fetal growth and neurodevelopment. Iron
is essential for normal fetal development of several vital
organs including the central nervous system [6]. In
support, iron deficiency has been related to preterm
delivery, low birth weight of the offspring, as well as iron
deficiency in the newborns [6]. We have previously
shown an increased frequency of anemia in our cohort
of pregnant women with a history of ED compared to
controls [1].
Maternal stressors have been related to small head
circumference and impaired cognitive performance in
the offspring [7]. It has been reported that women with
AN and BN have elevated circulating levels of neuroac-
tive stress hormones like cortisol [8]. Furthermore,
prenatal treatment with corticosteroids has been associ-
ated with neurodevelopmental abnormalities [9]. Hypo-
thetically, maternal hypercortisolism may therefore affect
brain development of the child.
There is also evidence that maternal thyroid hormone
function is of great importance for neuropsychological
development of the child. In a large study, Haddow and
co-workers [10] were first to demonstrate that undiag-
nosed maternal hypothyroidism was related to impaired
cognitive performance in the offspring at around eight
years of age. Furthermore, insulin and insulin-like
growth factors are important regulators of developmen-
tal and cognitive functions of the fetus [11]. Diabetes
during pregnancy can result in neurodevelopmental and
neurocognitive defects [12]. Even in children of well-
controlled diabetic mothers, fine and gross motor
function could be impaired and higher rate of inatten-
tion and/or hyperactivity have been demonstrated [12].
In the present study, we report results on serum
biomarkers of nutrition and stress (ferritin, cortisol,
thyroid-stimulating hormone (TSH), free thyroxine (T4),
insulin, insulin-like growth factor I (IGF-I) and IGF
binding protein 1 (IGFBP1)) during early pregnancy in
our cohort of women with a previous history of AN or
BN in comparison to controls and relate these data to
head circumference at birth and neurocognitive function
at five years of age of the child.
Methods
Participants
In this longitudinal cohort study, the initial study
population consisted of 49 women with a history of ED
(24 AN, 20 BN, 5 unspecified eating disorder) and mean
age ± SD 29.3 ± 4.6 years, and 67 control women aged
30.0 ± 3.7 years [1]. All women were nulliparous, non-
smokers and conceived spontaneously. They were
recruited in early pregnancy (gestational week 10) from
13 prenatal clinics in the northwest area of Stockholm
and followed throughout pregnancy and up to three
months post-delivery [1]. The women with a history of
ED were initially diagnosed by interview according to
the DSM-IV diagnostic criteria [13] and the diagnosis
was further confirmed from medical records when
available. The mean duration of ED was nine years
(range 3–15 years) and the duration of recovery before
study recruitment was 3.2 ± 3.0 (mean ± SD) years.
During the same time period, 68 controls were recruited
from the same prenatal clinics by interview, using the
same inclusion criteria as for the patients but without a
history of ED. Power calculation for the initial study
population was based on birth weight as the primary
outcome variable and the sample size was calculated to
detect a difference between patients and controls of
approximately 10 % with 80 % power [1].
In all women, a routine blood sample was collected
during early pregnancy (gestational week 10) in connec-
tion with the first visit at the prenatal clinic for screen-
ing of infections (hepatitis B, human immunodeficiency
virus infection, syphilis, rubella) and blood typing. After
analysis, remaining serum was stored at the biobank of
Karolinska University Hospital. All women gave their
consent for the sample to be used for research purposes.
Biobank samples from 37 women with a history of ED
(20 AN, 17 BN) and 59 controls were available for
analysis of biomarkers of nutrition and stress.
Neurocognitive development of the children was
investigated at the age of five years [5] using a
validated parent questionnaire, The Five to Fifteen
(FTF) [14–17], which was delivered by mail and
completed by the mothers. The FTF has relatively
high internal consistency and an accetable to excel-
lent inter-rater and test-retest reliability [14]. The
complete questionnaire consists of 181 items on
neurocognitive development divided into eight do-
mains (motor skills, executive functions, perception,
memory, language, learning, social skills and emo-
tional/behavioural problems) and their subdomains,
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but for children who are five years old the domain
learning is not used. Higher scores reflect difficulties
in neurocognitive function.
The present research protocol was approved by the
local Committee of Medical Ethics at the Karolinska
University Hospital (2011/815-32) and the Biobank of
Karolinska University Hospital (BbK-00682). Written
informed consent was obtained from all women.
Analytical methods
Serum levels of ferritin were analyzed by a routine
chemiluminescence assay at the Department of Clin-
ical Chemistry, Karolinska University Hospital. The
detection limit was 0.2 μg/L and the total coefficient
of variation (CV) was 8.6 %. Serum cortisol was
analyzed using the instrument Modular E170/Cobas
E (Roche Diagnostics, Mannheim, Germany). The
CV for total cortisol was 3.1 % at 284 nmol/L and
3.8 % at 750 nmol/L. The assay measures both the
free and protein-bound cortisol. Serum levels of
TSH and free T4 were measured with enzyme im-
munoassays involving direct chemiluminescence, as
described previously [18]. Insulin was analyzed using
a magnetic bead-based metabolic panel kit from
Millipore, Billerica, MA, USA (Cat# HMHMAG-34
K-06). The plate reader was a Luminex MagPix
(Millipore) and the plate washer was a Tecan Hydro-
flex (Tecan, Männedorf, Switzerland) fitted with a
magnetic holder. The inter-and intra-assay coeffi-
cients of variation were 12.5 % and 8.3 %. Serum
IGF-I was determined by radioimmunoassay follow-
ing separation from IGF-binding proteins by acidic
ethanol extraction and cryoprecipitation [19]. The
concentrations of IGFBP1 in serum samples were
determined by radioimmunoassay according to Póvoa
and co-workers [20].
Statistical analyses
All values are presented as means and standard devia-
tions, medians and inter-quartile ranges (P25–P75) or as
percentage. One-way analysis of variance (ANOVA) was
used to compare the three groups AN, BN and controls
followed by the LSD post-hoc test. Prior to these
analyses, certain variables were log-transformed and
reciprocal transformed to compensate for their positively
skewed distributions. When comparing IGF-I levels
between groups, differences in age were adjusted for
utilizing an age-adjusted score for this variable (IGF-I
SD-score). Associations between biomarkers of nutrition
and stress in mothers versus head circumference and
neurocognitive function in their children were calculated
using Spearman rank correlation or Pearson correlation
test. A two-sided p-value <0.05 was considered to be
statistically significant.
Results
Table 1 shows pregnancy and neonatal outcomes of the
study population. The AN women had significantly
lower maternal body mass index (BMI) at early preg-
nancy, lower maternal weight gain, increased frequency
of anemia (Hb < 110 g/L) and conceived infants with
smaller head circumference than controls. The BN
women had increased frequency of hyperemesis and
their infants had significantly reduced head circumfer-
ence at birth. Nine women (24 %) had verified relapse of
eating disorder during pregnancy, of which 8 were
diagnosed with previous AN and 1 with past BN.
The combined group of AN and BN had lower ferritin
levels than the controls (32 (21–54) vs 51 (26–76) μg/L,
Table 1 Pregnancy and neonatal characteristics in pregnant women
AN n = 20 BN n = 17 Controls n = 59
Age of the mothers, years 29.8 ± 5.6 29.4 ± 4.2 29.8 ± 3.9
Maternal BMI, kg/m2 18.9 ± 2.9 a***, b** 21.9 ± 3.0 22.5 ± 2.8
Maternal weight gain, kg 10.0 ± 3.8 a**, b** 12.9 ± 3.8 12.2 ± 2.7
Weeks of gestation 38.7 ± 2.1 39.0 ± 1.6 39.1 ± 1.8
Hyperemesis, % 20 47 a** 10
Anemia, % 70 a***, b* 29 12
Birth weight, kg 3.2 ± 0.6 3.3 ± 0.7 3.5 ± 0.5
Birth length, cm 49.5 ± 3.1 50.2 ± 2.1 50.2 ± 2.4
Head circumference, cm 33.6 ± 1.6 a*** 33.8 ± 0.88 a** 35.2 ± 1.6
SGA, % 10 12 3
Groups of mothers with a history of anorexia nervosa (AN) or bulimia nervosa (BN) and controls. Values are mean ± SD or percentage
Significant differences between groups are indicated: * p < 0.05, ** p < 0.01, *** p < 0.001
aAN or BN versus Controls, bAN versus BN
BMI, body mass index
SGA, small for gestational age
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p < 0.05). This was also true for the AN group (p < 0.01)
but not the BN group (Fig. 1). Twenty percent of the
patients (5 AN and 3 BN) and 12 % of the control
women had ferritin values below the normal range
for pregnant women (<20 μg/L). In the combined
groups of patients and controls, there was a positive
correlation between serum ferritin and head circum-
ference of the offspring at birth (rs = 0.21, p < 0.05).
There were no significant associations between these
variables in any of the separate groups. Serum ferritin
in the mothers with a history of AN, but not in those
with a history of BN, was significantly associated with
memory impairment of the offspring at five years of
age (rs = −0.70, p < 0.001) (Fig. 2).
Cortisol levels were comparable between groups with
the highest mean value in the control group (Table 2). In
the AN group only, there was a positive correlation
between cortisol and head circumference of the offspring
at birth (rs = 0.49, p < 0.05). Serum levels of TSH and
free T4 were also similar between groups (Table 2). Ten
percent of the women in the patient group and 8 % of
the control women had TSH levels > 2 mE/L. Maternal
TSH did not show any significant associations with
measures of head circumference and neurocognitive
function in any of the groups. However in the com-
bined patient group, maternal free T4 correlated posi-
tively to head circumference at birth (rp = 0.36, p < 0.05),
as in the BN group (rp = 0.48, p < 0.05), and with a similar
tendency in the AN group (rp = 0.42, p = 0.07), whereas
there was no such correlation in the control group
(rp = 0.006) (Fig. 3).
There were no significant differences in insulin, IGF-I
SD-score and IGFBP1 levels between groups (Table 2).
Maternal insulin correlated negatively to head circum-
ference at birth in the BN group (rp = −0.49, p < 0.05)
but not in the AN group (rp = −0.09, p = 0.70). Further-
more, serum levels of IGF-I SD-score correlated
positively with head circumference of the offspring at
birth in the patient group (rs = 0.38, p < 0.05) but not
in the separate groups.
Discussion
In the present study, women with a history of AN were
characterized by a low BMI in the 10th week of gestation,
a low weight gain during pregnancy, and a high preva-
lence of anemia in comparison to the BN and control
groups. Nonetheless, birthweight and length of the
offspring were not significantly different, but head
circumference was reduced in the infant to mothers with
a history of AN or BN. Our previous and other studies
have shown that head circumference is positively associ-
ated with childhood cognitive performance [5, 21].
We found low levels of maternal serum ferritin in
early pregnant women with a history of AN, which is in
agreement with a high frequency of anemia in this
group. Furthermore, there was a weak positive associ-
ation between ferritin levels and head circumference of
the offspring in the combined group of patients and
controls. Other studies have found associations between
both low and high levels of ferritin and various preg-
nancy complications, such as preterm birth, preeclamp-
sia and intrauterine growth restriction [22, 23]. It is well
established that serum ferritin during pregnancy is an
indicator of maternal iron stores, with low levels diag-
nostic of iron deficiency. However, under certain
clinical conditions high levels of ferritin, particularly
during the third trimester, may be secondary to acute-
phase reaction and rather indicate an acute or chronic
infection [22]. This may explain the previously reported
diverse associations between maternal ferritin and
pregnancy complications.
We have demonstrated earlier that children born to
mothers with a history of ED, and particularly to those
with previous AN, had significantly impaired motor skills,
memory capacity, language skills and social skills than
control children at five years of age [5]. In the present
study of the same cohort, we found that low serum ferritin
in the mothers with a history of AN, but not in those with
a history of BN, was associated with impaired memory of
the offspring at five years of age. These observations
suggest that deficient iron stores in the AN mothers may
be of importance for neurocognitive development of the




















Fig. 1 Serum levels of ferritin in the group of mothers with a
history of anorexia nervosa (AN) (n = 20) or bulimia nervosa
(BN) (n = 17) and controls (n = 59). The dashed line indicates
the normal lower range for pregnant women. Values are
medians and inter-quartile ranges (P25–P75). **p < 0.01 in
comparison to controls
Koubaa et al. BMC Pregnancy and Childbirth  (2015) 15:318 Page 4 of 8
mechanisms for the development of neurocognitive
impairment in children of mothers with a history of AN
and BN.
Our study did not demonstrate maternal hypercortiso-
lism in the mothers with previous ED. Furthermore, we
found somewhat unexpectedly, a positive correlation be-
tween maternal serum cortisol and head circumference at
birth in the AN group. This finding gives no support for
our hypothesis of a link between a high maternal serum
cortisol level in mothers with ED and a reduced head cir-
cumference in the offspring [1, 5]. It is known that anemia
and iron deficiency can induce maternal and fetal stress
which stimulates the synthesis of corticotropin – releasing
hormone (CRH) [24]. Elevated CRH is a major risk factor
for preterm labor and also increases fetal cortisol produc-
tion which may inhibit growth of the fetus. Maternal neur-
oticism was found to increase the risk for fetal weight
restriction and head circumference restriction [25]. Fur-
thermore, prenatal maternal objective stress was positively
related to lower cognitive and language abilities at five
years of age of the offspring [26]. However, maternal
Controls











































































































Fig. 2 Correlations between maternal serum levels of ferritin and raw scores of memory function of the offspring at five years of age. Groups of
mothers with a history of anorexia nervosa (AN) (n = 20), bulimia nervosa (BN) (n = 17), the combined groups of patients (n = 37) and controls
(n = 59). Higher scores reflect impaired function
Table 2 Serum levels of biomarkers of nutrition and stress in
pregnant women
AN BN Controls
n = 20 n = 17 n = 59
Cortisol, nmol/L 401 ± 141 374 ± 121 418 ± 147
TSH, mIU/L 0.80 (0.51–1.08) 1.01 (0.62–1.17) 0.85 (0.51–1.30)
Free T4, pmol/L 16.7 ± 2.0 17.2 ± 3.8 17.4 ± 2.4
Insulin, pg/mL 100 (68–258) 94 (73–291) 138 (56–275)
IGF-I SD-score −1.47 ± 0.80 −1.17 ± 0.95 −1.35 ± 1.02
IGFBP1, μg/L 149 ± 84 110 ± 55 120 ± 62
Groups of mothers with a history of anorexia nervosa (AN) or bulimia nervosa
(BN) and controls. Values are mean ± SD or median and inter-quartile range
IGF-I, insulin like growth factor-I
IGFBP1, IGF binding protein 1
SD-score, age-adjusted score
T4, thyroxine
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prenatal stress and/or maternal serum cortisol are in some
studies positively related to fetal weight and development
but data are sometimes conflicting [7, 27].
We found no differences in maternal serum levels of
TSH and free T4 between groups. Low maternal levels of
free T4 in early pregnancy are related to a delay of expres-
sive language and nonverbal cognitive ability in early child-
hood of the offspring [28]. Furthermore, increased maternal
serum TSH is associated with lower intelligence and motor
scores of the child [10, 28]. Our finding of a positive associ-
ation between serum free T4 in pregnant women with a
history of BN or AN and head circumference at birth of the
offspring could be in line with the above results.
In this study, we found a positive correlation between
maternal IGF-I and head circumference of the child in
the patient group. A positive relationship between
maternal serum IGF-I and birth weight of the infant has
previously been reported [29]. In agreement, our result
may further support a role of IGF in fetal growth.
Furthermore, good control of diabetes during pregnancy
is essential to improve fetal growth [30]. Pregestational,
as well as, gestational diabetes are associated with lower
offspring cognition and educational attainment [12, 31].
The finding of a negative correlation between maternal
serum insulin and head circumference at birth may be in
agreement with this although our mothers were not dia-
betic. However, this association was significant only in the
BN group and not in the mothers with a history of AN.
There are several limitations with the present study.
Determination of serum biomarkers was performed only
in one blood sample collected during early pregnancy
and the results may therefore not be representative for
the course of pregnancy. The blood sample was collected
under non-fasting conditions and not standardized. The
sample size was also limited. Furthermore, the FTF
questionnaire was based on parent information of the
mothers. Although the FTF test has demonstrated high
inter-rater and test-retest reliability and validity, we
cannot exclude reporter bias due to the possibility of
worries and feelings of guilt in the mothers with a history
of ED. Strength of the study is the longitudinal cohort
design of area-based consecutive sampling of women with
previous ED and controls and that only nulliparous, non-
smoking women were included. We were also able to
AN



























































































































Fig. 3 Correlations between maternal serum levels of free T4 and head circumference of the offspring at birth. Groups of mothers with a history
of anorexia nervosa (AN) (n = 20), bulimia nervosa (BN) (n = 17), the combined groups of patients (n = 37) and controls (n = 59)
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correlate maternal biomarkers with previous data on head
circumference of the offspring at birth and neurocognitive
function in the children at five years of age.
Conclusions
Low maternal serum ferritin in the AN group, but not in
the BN group, seems to be of importance for impaired
memory capacity in the offspring at five years of age.
Women with a history of ED, and particularly of AN,
should be recognized as at-risk patients for anemia
during pregnancy and be adequately treated to prevent
potential negative outcomes of the offspring. Further-
more, the positive association between serum free T4 in
pregnant mothers with previous ED and head circumfer-
ence of the offspring suggests that maternal thyroid
hormone function also is important for the child’s head
growth and cognitive development.
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